Tag Archives: PrEP

Awareness and use of HIV pre-exposure prophylaxis (PrEP) among black gay, bisexual and other men who have sex with men (MSM) in the United States increased significantly between 2014 and 2017, according to research published in 1 November edition of the Journal of Acquired Immune Deficiency Syndromes. The study also showed that PrEP was reaching… Read More »

A small removable plastic implant resembling a tiny piece of dry spaghetti is capable of delivering sustained levels of the drug tenofovir, researchers told last month’s HIV Research for Prevention conference (HIVR4P) in Madrid. The drug delivery capability of the implants was tested on rabbits and will now advance into tests on dogs and non-human… Read More »

A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal… Read More »